Literature DB >> 6311542

The effect of quercetin on the phosphorylation activity of the Rous sarcoma virus transforming gene product in vitro and in vivo.

Y Graziani, E Erikson, R L Erikson.   

Abstract

The phosphotransferase activity of the Rous sarcoma virus src gene product, pp60src, was inhibited both in vitro and in vivo by the bioflavonoid quercetin. The Ki for the inhibitory effect was in the range of 6-11 microM under conditions in vitro. The inhibitory effect of quercetin was competitive towards the nucleotides ATP and GTP as substrates for pp60src and was non-competitive towards alpha-casein as the protein substrate of this kinase activity. In contrast, studies in vitro of the phosphotransferase activity of the catalytic subunit of the cAMP-dependent protein kinase showed that this flavonoid did not inhibit the phosphorylation of physiological substrates of this enzyme. In cultured cells the half-maximal inhibition of tyrosine phosphorylation of pp60src as well as the phosphorylation of the Mr = 34000 protein, a physiological substrate of pp60src, was in the range 0.06-0.08 mM.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311542     DOI: 10.1111/j.1432-1033.1983.tb07692.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  26 in total

Review 1.  Treatment for chronic myelogenous leukemia: the long road to imatinib.

Authors:  Tony Hunter
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1.

Authors:  Heidi C Dodson; Todd A Lyda; Jeremy W Chambers; Meredith T Morris; Kenneth A Christensen; James C Morris
Journal:  Exp Parasitol       Date:  2010-11-11       Impact factor: 2.011

3.  Phosphatidylinositol kinase activity in virus-transformed and nontransformed cells.

Authors:  S Sugano; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

4.  A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

Authors:  Julia Reis; Xiaoyu Tan; Rongjie Yang; Cheryl E Rockwell; Christopher J Papasian; Stefanie N Vogel; David C Morrison; Asaf A Qureshi; Nilofer Qureshi
Journal:  Innate Immun       Date:  2008-10       Impact factor: 2.680

5.  Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).

Authors:  M R Vijayababu; A Arunkumar; P Kanagaraj; P Venkataraman; G Krishnamoorthy; J Arunakaran
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

Review 6.  Cell-signaling targets for antitumour drug development.

Authors:  V G Brunton; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Authors:  Y Sugimoto; M Whitman; L C Cantley; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Suppression of the proliferation and migration of oncogenic ras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules.

Authors:  H Q Lü; B Niggemann; K S Zänker
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Variation in expression and protein localization of the PIN family of auxin efflux facilitator proteins in flavonoid mutants with altered auxin transport in Arabidopsis thaliana.

Authors:  Wendy Ann Peer; Anindita Bandyopadhyay; Joshua J Blakeslee; Srinivas N Makam; Rujin J Chen; Patrick H Masson; Angus S Murphy
Journal:  Plant Cell       Date:  2004-06-18       Impact factor: 11.277

Review 10.  Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.

Authors:  Eyal Mishani; Galith Abourbeh; Martin Eiblmaier; Carolyn J Anderson
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.